Useful Management Information

  • Chronic cough is frequently associated with underlying airway hypersensitivity. Many other factors can be contributory, categorised into:
    • respiratory
    • drug related (ACE inhibitors)
    • gastrointestinal (symptomatic GORD)
    • ENT (symptomatic rhinosinusitis; laryngeal hypersensitivity)

Treatment options:

  • ACE inhibitors should be ceased for at least 6 weeks, and an alternate medication substituted as required (e.g. angiotensin 2 receptor antagonists).
  • Ensure asthma, symptomatic acid reflux (heartburn), sino-nasal disease, and unresolved infectious bronchitis and have been considered and treated appropriately.
  • Commence a four-week trial of inhaled steroids for evidence of asthma (typical symptoms, atopy, obstructive spirometry, raised blood eosinophils or FeNO)
  • Four-week trial of PPI if symptoms of heartburn
  • Consider a six-week trial of intra nasal steroid for features of chronic rhinosinusitis

NOTE: in the absence of specific diagnostic features, ‘blind’ trials of treatment of secondary diseases (asthma, GORD, rhinosinusitis, etc) are no longer advocated for chronic cough

Clinician resources

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category 1 (appointment within 30 calendar days)
  • No category 1 criteria
Category 2 (appointment within 90 calendar days)
  • Recurrent cough syncope in the presence of cough persisting >8 weeks
Category 3 (appointment within 365 calendar days)
  • Cough present for > 8 weeks with normal Chest X-Ray and normal spirometry and no improvement following treatment trial as specified in Useful Management Information
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service.

Essential Referral Information

  • Associated effects such as syncope, incontinence, SOB
  • FBC, ELFT and ESR
  • CT chest
  • History of smoking, occupational exposures, respiratory or ENT problems, or GORD
  • Medication history, especially including ACE inhibitor use (which should be avoided), and results of treatment trials as defined in Other useful information
  • Relevant examination findings

Additional Referral Information

  • Spirometry and FeNO result (exhaled nitric oxide) if available
  • CXR, if performed
  • Previous gastroscopy findings or ENT assessment details where relevant
Last updated 1 December 2024

Send Referrals To

Smart Referrals

Preferred Method
About Smart Referrals

Secure Web Transfer

Send to: Gold Coast Health Service District

Internal Referrals

Respiratory (E-Blueslips)
Sleep Clinic Adult (E-Blueslips)

Fax

(07) 5687 4497

Post

Booking and Referral Centre
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 559 083

Related HealthPathways

No directly related pathways found

Service Availability

Dr Maninder Singh
Medical Director Respiratory and Sleep Medicine

Facilities

Gold Coast University Hospital
Robina Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.